Ardena
A European CDMO offering polymorph, salt, cocrystal, and amorphous-form screening and crystallization development.
Corporate information
- Company entity
- Ardena
- Headquarters / principal office
- GhentSelf-reported location on the company LinkedIn page; regional scope may differ from the legal or global headquarters. ↗
- Founded
- 2017 ↗
- Ownership / capital status
- PrivatePrivate equity-controlled / privately held ↗
- Official corporate reference
- https://ardena.com/services/drug-product/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
The website's service FAQ explicitly lists high-throughput salt, polymorph, cocrystal, and ASD screening.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.